Drug intelligence / Profile preview

Ad5luc1

Development stage
Preclinical
Lead developer
University of Helsinki
Modality
Gene Therapies
Administration
Intravenous, Intratumoral
01

Overview

Ad5luc1 is a replication-deficient adenoviral vector based on the human adenovirus serotype 5 (Ad5) platform. It is characterized by a deletion in the E1 region of the viral genome, which prevents it from replicating in non-complementing cell lines, and the inclusion of a luciferase reporter gene, typically driven by a Cytomegalovirus (CMV) promoter. In oncology and gene therapy research, Ad5luc1 is primarily utilized as a negative control for oncolytic (replication-competent) adenoviruses. It allows researchers to distinguish between biological effects resulting from initial viral transduction and transgene expression versus those caused by active viral replication and subsequent oncolysis. The vector utilizes the Coxsackievirus and Adenovirus Receptor (CAR) for cellular entry via its wild-type fiber protein.

Other names
Ad5-CMV-lucAd-5-CMV-lucAd 5-CMV-lucAd5-lucAd-5-lucAd 5-luc
02

Targets

CXADR (Coxsackievirus and adenovirus receptor)

Beyond the preview

Go deeper on Ad5luc1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ad5luc1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call